Colorado Prevention Center

3 trials 3 recruiting Commercial sponsor

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

11 Countries active

2 Unique IMPs

N/A Results reported

Phase III

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Top IMPs

FINERENONE 3 EMPAGLIFLOZIN 1

All trials

3 total

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATI… Recruiting

2023-508874-27-00 Phase III 1 country EMPAGLIFLOZIN; FINERENONE
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme… Recruiting

2023-508875-35-00 Phase III 7 countries FINERENONE
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Phase III 11 countries FINERENONE

Showing 1–3 of 3 trials

← All sponsors A–Z